Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 388.9 million compared to CNY 347.6 million a year ago. Net income was CNY 181.14 million compared to CNY 147.32 million a year ago. Basic earnings per share from continuing operations was CNY 0.346 compared to CNY 0.2814 a year ago.